|
Structural insights into substrate specificity and the relationship between T4 and eukaryotic Pnk
Mammals and fission yeast contain a bifunctional Pnk enzyme with 5'-kinase and 3'-phosphatase activities analogous to those of T4 Pnk. However, whereas T4 Pnk phosphorylates 5' OH ends of RNA, DNA and nucleo side 3' monophosphates, the eukaryotic Pnk enzymes are specific for 5' OH DNA substrates. The primary structures of the kinase components of the T4 and eukaryotic Pnks are similar and four of the five amino acids that are essential for catalysis and comprise the active site in the T4 Pnk crystal structure (Lys15, Ser16, Asp35 and Arg126) are conserved in human and Schizosaccharomyces pombe Pnks (Jilani et al., 1999a; Karimi-Busheri et al., 1999; Meijer et al., 2002). Thus, we surmise that T4 and eukaryotic Pnk kinase domains are likely to have similar folds with highly conserved binding sites for the NTP phosphate donor and a similar mechanism of catalysis involving an essential aspartate side chain (equivalent to Asp35 in T4 Pnk). The striking difference is that none of the eukaryotic Pnk proteins contains a basic side chain at the position corresponding to Arg38 of T4 Pnk, an essential residue that makes a bidentate contact with the 3' phosphate of the terminal nucleotide of the phosphate acceptor. The existence of a dedicated electrostatic interaction with the 3' phosphate almost certainly accounts for the ability of T4 Pnk to phosphorylate 3' NMPs, whereas the lack of an equivalent arginine in the mammalian Pnk suffices to explain its failure to utilize 3' dNMP as a substrate (Jilani et al., 1999b). Indeed, mammalian Pnk requires that the phosphate acceptor have a minimum chain length of approximately eight deoxynucleotides for the kinase reaction to occur (Karimi-Busheri and Weinfeld, 1997).
Other fundamental differences in the phosphate acceptor specificities of T4 versus mammalian Pnks are clarified by the structure of the T4 domain. Although T4 Pnk is widely used to label DNA 5' ends in vitro, it is actually quite selective in phosphorylating DNAs with 5' single-strand extensions; T4 Pnk is poorly active or inactive on blunt duplex 5' OH termini or 5' OH termini that are recessed within duplex regions or at the junction of a 3' single-strand tail (Jilani et al., 1999b). The crystal structure of the T4 kinase domain indicates that the tunnel aperture leading to the 3' phosphate binding site of the phosphate acceptor (Figure 3) is too narrow to allow facile ingress of duplex nucleic acid, but can readily accommodate a single-stranded polynucleotide. The physiological substrates of T4 Pnk in vivo are broken tRNAs incised 5' to the wobble base of the anticodon loop (Amitsur et al., 1987). The resulting 5' OH end at the break is free to enter the T4 kinase active site as a five nucleotide single-strand extension coming off the anticodon stem. Unlike T4 Pnk, the mammalian kinase preferentially phosphorylates 5' ends recessed within duplex DNA structures (Karimi-Busheri and Weinfeld, 1997), implying that the phosphate acceptor site of the mammalian Pnk is fundamentally different from that of the phage T4 enzyme.
The most obvious structural differences between the T4 and eukaryotic Pnks are that (i) the H2N-kinase/phosphatase-COOH domain order of T4 Pnk is inverted in the eukaryotic enzymes as H2N-phosphatase/kinase-COOH (Jilani et al., 1999a; Karimi-Busheri et al., 1999; Meijer et al., 2002) and (ii) T4 Pnk is a 140 kDa homotetramer, whereas the human Pnk is a 60 kDa monomer (Mani et al., 2001). The evolutionary forces shaping the divergence in both domain order and quaternary structure in 'RNA repair' versus 'DNA repair' Pnks are unclear and their elucidation will hinge on obtaining additional atomic structures of the native enzymes from diverse sources.
Materials and methods Crystallization and data collection
Recombinant His-Pnk(1−181) was purified from soluble E.coli extracts by Ni−agarose chromatography as described previously (Wang and Shuman, 2001), except that Triton X-100 was omitted from the lysis and column buffers. Crystals of His-Pnk(1−181) were grown at 22°C by the hanging drop vapor diffusion method. The protein sample (7 mg/ml in 50 mM Tris−HCl pH 7.5, 0.2 M NaCl, 0.3 M imidazole, 10% glycerol) was mixed with an equal volume of the reservoir buffer containing 100 mM of sodium acetate pH 4.6, 5 mM DTT, 16% PEG-2000 monomethyl ether and 0.4 M ammonium sulfate. Crystals were grown over 2 days to 1 week. Prior to diffraction, the crystals were cryo-preserved in reservoir buffer containing 30% glycerol and then flash-frozen in liquid nitrogen. X-ray diffraction data for a native crystal were collected at the National Synchrotron Light Source (Brookhaven, NY) at beamline X9A using an MAR CCD detector. Diffraction data for a mercury acetate derivative were collected at a laboratory copper K source (Rigaku RU200) equipped with a confocal Osmic multilayer system and a Raxis-IV imaging plate detector system. Data were integrated, scaled and merged using DENZO and SCALEPACK (Otwinowski and Minor, 1997). Pnk(1−181) crystallized in space group C2221 (a = 65.3 Å, b = 91.8 Å, c = 67.9 Å; , and = 90°).
Structure determination and refinement
The Pnk structure was solved by single isomorphous replacement with anomalous scattering. Phases (2.0Å) were calculated with SOLVE/RESOLVE (Terwilliger and Berendzen, 1999) and the CCP4 suite (Collaborative Computational Project, 1994). The model was built manually into the electron density map using the program O (Jones et al., 1991). Refinement was performed with CNS (Brunger et al., 1998). The refined model at 2.0 Å resolution (Rfree = 23.3, R = 21.0) consists of Pnk residues 1−152, 142 waters and four sulfates. No electron density was observed for the N-terminal His-tag and for amino acids 153−181. All of the amino acids are found within the most favored or allowed regions in the Ramachandran plot. Refinement statistics are listed in Table I. The coordinates are deposited in the Protein Data Bank under code 1LY1. Images of the Pnk structure were prepared with SETOR (Evans, 1993).
Pnk mutants
N-terminal deletion mutants Pnk(139−301) [N 138], Pnk(149−301) [N 148] and Pnk(159−301) [N 158] were constructed by PCR amplification with mutagenic sense-strand primers that introduced an NdeI restriction site and a methionine codon in lieu of the codon for 138, 148 or 158. Alanine mutations were introduced into the full-length Pnk gene by using the two-stage PCR-based overlap extension method. The PCR products were digested with NdeI and BamHI and then inserted into pET16b. The inserts were sequenced completely to confirm the desired mutations and to exclude the acquisition of unwanted changes. The pET-Pnk and pET-Pnk-Ala plasmids were introduced into E.coli BL21(DE3)-CodonPlus and the truncated or Ala-substituted Pnk were purified from soluble bacterial lysates as described for the wild-type Pnk (Wang and Shuman, 2001). Protein concentrations were determined by using the Bio-Rad dye reagent with BSA as the standard.
5'-kinase assay
Reactions mixtures (10 l) containing 70 mM Tris−HCl pH 7.6, 10 mM MgCl2, 5 mM DTT, 25 M [ -32P]ATP, 1 mM 3' CMP (Sigma) and Pnk as specified were incubated for 20 min at 37°C. Aliquots of the mixtures were applied to a polyethyleneimine-cellulose TLC plate, which was developed with 1 M formic acid and 0.5 M LiCl. The [ -32P]ATP substrate and [ -32P]pCp product were visualized and quantitated by scanning the gel with a Fujix BAS2500 phosphoimager.
3'-phosphatase assay
Reaction mixtures (25 l) containing 100 mM imidazole pH 6.0, 10 mM MgCl2, 10 mM -mercaptoethanol, 0.1 mg/ml BSA, 1.6 mM 3' dTMP (Sigma) and Pnk as specified were incubated for 20 min at 37°C. The reactions were quenched by adding 75 l of cold water and 1 ml of malachite green reagent (BIOMOL Research Laboratories). Phosphate release was determined by measuring A620 and extrapolating the value to a phosphate standard curve.
Velocity sedimentation
Aliquots (40 g) of the Pnk preparations were mixed with BSA (30 g), ovalbumin (30 g) and cytochrome c (30 g) and the mixtures were applied to 4.8-ml 15−30% glycerol gradients containing 50 mM Tris−HCl pH 8.0, 0.2 M NaCl, 1 mM EDTA, 2.5 mM DTT and 0.1% Triton X-100. The gradients were centrifuged in a SW50 rotor at 50 000 r.p.m. for 24 h at 4°C. Fractions were collected from the bottoms of the tubes.
Acknowledgements
We thank the staff of beamline X9A at the National Synchrotron Light Source. This research was supported by NIH grant GM42498 (to S.S.) and a Young Investigator Award from the Arnold and Mabel Beckman Foundation (to C.D.L.).
References
Abele U and Schulz GE (1995) High-resolution structures of adenylate kinase from yeast liganded with inhibitor Ap5A, showing the pathway of phosphoryl transfer. Protein Sci, 4, 1262–1271. | PubMed | ISI | ChemPort | Abelson J, Trotta CR and Li H (1998) tRNA splicing. J Biol Chem, 273, 12685–12688. | Article | PubMed | ISI | ChemPort | Amitsur M, Levitz R and Kaufman G (1987) Bacteriophage T4 anticodon nuclease, polynucleotide kinase, and RNA ligase reprocess the host lysine tRNA. EMBO J, 6, 2499–2503. | PubMed | ISI | ChemPort | Becker A and Hurwitz J (1967) The enzymatic cleavage of phosphate termini from polynucleotides. J Biol Chem, 242, 936–950. | PubMed | ISI | ChemPort | Berry MB and Phillips GN (1998) Crystal structures of Bacillus stearothermophilus adenylate kinase with bound Ap5A, Mg2+ Ap5A, and Mn2+ Ap5A reveal an intermediate lid position and six coordinate octahedral geometry for bound Mg2+ and Mn2+. Proteins, 32, 276–288. | Article | PubMed | ISI | ChemPort | Brunger AT et al. (1998) Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr D, 54, 905–921. | Article | PubMed | ISI | ChemPort | Cameron V and Uhlenbeck OC (1977) 3'-Phosphatase activity in T4 polynucleotide kinase. Biochemistry, 16, 5120–5126. | PubMed | ISI | ChemPort | Collaborative Computational Project (1994) The CCP4 suite: programs for protein crystallography. Acta Crystallogr D, 50, 760–763. Dreusicke D, Karplus PA and Schulz GE (1988) Refined structure of porcine cytosolic adenylate kinase at 2.1 Å resolution. J Mol Biol, 199, 359–371. | PubMed | ISI | ChemPort | Evans SV (1993) SETOR: hardware-lighted three-dimensional solid model representations of macromolecules. J Molec Graph, 11, 134–138. | Article | ISI | ChemPort | Hasemann CA, Istvan ES, Uyeda K and Deisenhofer J (1996) The crystal structure of the bifunctional enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase reveals distinct domains homologies. Structure, 4, 1017–1029. | PubMed | ISI | ChemPort | Holm L and Sander C (1993) Protein structure comparison by alignment of distant matrices. J Mol Biol, 233, 123–138. | Article | PubMed | ISI | ChemPort | Izard T and Ellis J (2000) The crystal structures of chloramphenicol phosphotransferases reveal a novel inactivation mechanism. EMBO J, 11, 2690–2700. | Article | Jarvest RL and Lowe G (1981) The stereochemical course of the phosphoryl transfer reaction catalyzed by polynucleotide kinase (bacteriophage-T4-infected Escherichia coli B). Biochem J, 199, 273–276. | PubMed | ISI | ChemPort | Jilani A, Ramotar D, Slack C, Ong C, Yang XM, Scherer SW and Lasko DD (1999a) Molecular cloning of the human gene, PNKP, encoding a polynucleotide kinase 3'-phosphatase and evidence for its role in repair of DNA strand breaks caused by oxidative damage. J Biol Chem, 274, 24176–24186. | Article | PubMed | ISI | ChemPort | Jilani A, Slack C, Matheos D, Zannis-Hadjopoulos M and Lasko DD (1999b) Purification of a polynucleotide kinase from calf thymus, comparison of its 3'-phosphatase domain with T4 polynucleotide kinase, and investigation of its effect on DNA replication in vitro. J Cell Biochem, 73, 188–203. | Article | ISI | ChemPort | Jones TA, Zou JY, Cowan SW and Kjeldgaard M (1991) Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A, 47, 110–118. | Article | PubMed | ISI | Karimi-Busheri F and Weinfeld M (1997) Purification and substrate specificity of polydeoxynucleotide kinases isolated from calf thymus and rat liver. J Cell Biochem, 64, 258–272. | Article | PubMed | ChemPort | Karimi-Busheri F et al. (1999) Molecular characterization of a human DNA kinase. J Biol Chem, 274, 24187–24194. | Article | PubMed | ISI | ChemPort | Krell T, Coggins JR and Lapthorn AJ (1998) The three-dimensional structure of shikimate kinase. J Mol Biol, 278, 983–997. | Article | PubMed | ISI | ChemPort | Lillehaug JR (1977) Physicochemical properties of T4 polynucleotide kinase. Eur J Biochem, 73, 499–506. | PubMed | ISI | ChemPort | Mani RS, Karimi-Busheri F, Cass CE and Weinfeld M (2001) Physical properties of human polynucleotide kinase: hydrodynamic and spectroscopic studies. Biochemistry, 40, 12967–12973. | Article | PubMed | ISI | ChemPort | Meijer M, Karimi-Busheri F, Huang TY, Weinfeld M and Young D (2002) Pnk1, a DNA kinase/phosphatase required for normal response to DNA damage by -radiation or camptothecin in Schizosaccharomyces pombe. J Biol Chem, 277, 4050–4055. | Article | PubMed | ISI | ChemPort | Midgley CA and Murray NE (1985) T4 polynucleotide kinase; cloning of the gene (pseT) and amplification of its product. EMBO J, 4, 2695–2703. | PubMed | ISI | ChemPort | Müller CW and Schulz GE (1992) Structure of the complex between adenylate kinase from Escherichia coli and the inhibitor Ap5A refined at 1.9 Å resolution: a model for a catalytic transition state. J Mol Biol, 224, 159–177. | PubMed | ISI | ChemPort | Novogrodsky A and Hurwitz J (1966) The enzymatic phosphorylation of ribonucleic acid and deoxyribonucleic acid: phosphorylation at 5'-hydroxyl termini. J Biol Chem, 241, 2923–2932. | PubMed | ISI | ChemPort | Novogrodsky A, Tal M, Traub A and Hurwitz J (1966) The enzymatic phosphorylation of ribonucleic acid and deoxyribonucleic acid: further properties of the 5'-hydroxyl polynucleotide kinase. J Biol Chem, 241, 2933–2943. | PubMed | ISI | ChemPort | Otwinowski Z and Minor W (1997) Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol, 276, 307–326. | Article | PubMed | ISI | ChemPort | Panet A, van de Sande JH, Loewen PC, Khorana HG, Raae AJ, Lillehaug JR and Kleppe K (1973) Physical characterization and simultaneous purification of bacteriophage T4 induced polynucleotide kinase, polynucleotide ligase, and deoxyribonucleic acid polymerase. Biochemistry, 12, 5045–5050. | Article | PubMed | ISI | ChemPort | Richardson CC (1965) Phosphorylation of nucleic acid by an enzyme from T4 bacteriophage-infected Escherichia coli. Proc Natl Acad Sci USA, 54, 158–165. | PubMed | ChemPort | Soltis DA and Uhlenbeck OC (1982a) Isolation and characterization of two mutant forms of T4 polynucleotide kinase. J Biol Chem, 257, 11332–11339. | PubMed | ChemPort | Soltis DA and Uhlenbeck OC (1982b) Independent location of kinase and 3'-phosphatase activities on T4 polynucleotide kinase. J Biol Chem, 257, 11340–11345. | ChemPort | Terwilliger TC and Berendzen J (1999) Automated MAD and MIR structure solution. Acta Crystallogr D, 55, 849–861. | Article | PubMed | ISI | ChemPort | Wang LK and Shuman S (2001) Domain structure and mutational analysis of T4 polynucleotide kinase. J Biol Chem, 276, 26868–26874. | Article | PubMed | ISI | ChemPort | Wang LK and Shuman S (2002) Mutational analysis defines the 5'-kinase and 3'-phosphatase active sites of T4 polynucleotide kinase. Nucleic Acids Res, 30, 1073–1080. | Article | PubMed | ISI | ChemPort | Whitehouse CJ, Taylor RM, Thistlethwaite A, Zhang HM, Karimi-Busheri F, Lasko DD, Weinfeld M and Xaldecott KW (2001) XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair. Cell, 104, 107–117. | Article | PubMed | ISI | ChemPort |
|